Targeted Alpha Therapy (TAT) has emerged as one of the most powerful cancer treatment available thanks to its ability to cause large amounts of damage near a tumor cell while keeping the healthy surrounding tissue intact.
NIDC News
Christopher Landers’ path to the DOE Isotope Program wasn’t planned. Instead, passion, experience and a drive to make an impact gradually led him there.
Construction of the single-story, 64,000-square-foot U.S. Stable Isotope Production and Research Center (SIPRC), funded by the DOE Isotope Program, is expected to take two years and be completed in Spring 2027.
In recent years, tungsten-188 (W-188) has gained traction in the nuclear medicine community because of the therapeutic and diagnostic value of its daughter isotope, rhenium-188.
DOE Isotope Program Highlights
Spherical Powders Enable New Applications for Metals
Free-flowing metal powders offer improvements for additive manufacturing, isotope production target fabrication, and more.
New Understanding of Astatine’s Chemical Properties Will Aid Targeted Alpha Therapy for Cancer
Recently, scientists at Texas A&M University investigated astatine’s behavior when interacting with ion exchange and extraction chromatography resins.
A First Look Inside Radium’s Solid-State Chemistry
Researchers used single crystal X-ray diffraction to learn about the structure and bonding of a highly radioactive radium compound.
